Certified to Export Webinar: December 9, 2025
As the Canadian cannabis market matures, the next frontier for growth is unequivocally international. For Licensed Producers (LPs) looking to move beyond domestic competition and access new, high-value medical markets, understanding global certification is non-negotiable.
Join Control Union Canada on Tuesday, December 9, 2025, at 2:00 pm Eastern Time/11 am Pacific Time for a free webinar, “Certified to Export: Connecting Canadian Cannabis to the World.” This session is designed for both micro and large producers who need a clear roadmap for international trade.
The expert-led discussion will dive deep into the crucial steps required to transition from Health Canada compliance to meeting the stringent demands of global buyers. Attendees will learn:
- How to bridge the gap between Canadian standards and international certifications like GACP (Good Agricultural Collection Practices), IMC GAP, and GMP (Good Manufacturing Practices).
- The essential role that quality assurance and stability testing play in securing international contracts.
- Best practices for export logistics, including the function of tollers, to ensure smooth distribution.
- What global buyers specifically expect from Canadian suppliers to gain credibility and market access.
Control Union Canada is a third-party certification body that provides international compliance audits. The organization helps Licensed Producers (LPs) achieve globally recognized standards like Good Agricultural and Collection Practices (GACP) and Good Manufacturing Practices (GMP), which are required to export medical cannabis to high-value markets like the EU, Israel, and Australia.
For more information including how to register visit:
https://northamerica.controlunion.com/certified-to-export-connecting-canadian-cannabis-to-the-world/
Beyond Borders: Positioning Canadian Cannabis for the Global Export Market
The Global Opportunity: Why Canadian Cannabis is Primed for Export Growth
Canada has long held a first-mover advantage in the global cannabis ecosystem. Since federal legalization, Canadian producers have established world-class cultivation and processing standards that are highly valued on the international stage. As more countries open their doors to medical cannabis—particularly in Europe, Australia, and Israel—exporting is becoming a vital strategy for those looking to diversify revenue and mitigate challenges in the saturated domestic market.
The demand for pharmaceutical-grade cannabis continues to rise globally. For Canadians, the international stage is not just a secondary market; it’s a critical component of long-term economic sustainability.
Bridging the Compliance Gap: From Health Canada to the World
While Health Canada’s licensing is the foundation, accessing most international markets requires an extra layer of compliance, most notably Good Manufacturing Practices (GMP) certification. The critical points in this process are as follows.
- Certification: For producers targeting Europe, obtaining EU-GMP certification or an equivalent international standard (such as IMC GAP/GACP) is essential. This signals to global buyers that your product meets the strict quality assurance and control standards required for medical products.
- Leverage Quality: Canadian-produced cannabis is often seen as a premium product. Producers should lean into this advantage by emphasizing specialized genetics, consistency, and stability testing, which are paramount for long-term supply contracts.
- Strategic Partnerships: Working with GMP-certified distributors, logistics experts, and experienced global consultants can streamline the complex process of international customs, tariffs, and differing regulatory requirements across jurisdictions.
By intentionally building an export-ready operation today, Canadian producers can move beyond domestic competition and solidify their role as reliable, high-quality suppliers in the expanding global market. The time to look outward is now.
AirMed was designed for export markets and meets GMP and GACP standards.
For more information visit our Software page.
Or visit our Compliance page.